(Hetero)aroyl esters of 2-(N-phthalimido)ethanol and analogues: Parallel synthesis, anti-HIV-1 activity and cytotoxicity

Medicinal Chemistry Research

Volumn 19, Issue 4, 2010, Pages 311-336

  Cesarini, Sara ^a   Spallarossa, Andrea ^a   Ranise, Angelo ^a   Schenone, Silvia ^a   La Colla, Paolo ^b   Collu, Gabriella ^b   Sanna, Giuseppina ^b   Loddo, Roberta ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Anti HIV 1 activity; Cytotoxicity; Esters; Parallel synthesis

Indexed keywords

2 (N PHTHALIMIDO)ETHANOL; ANTIRETROVIRUS AGENT; EFAVIRENZ; ESTER DERIVATIVE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; TROVIRDINE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME ASSAY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77954088920     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-009-9192-x     Document Type: Article

References (29)

1. M Artico R Silvestri S Massa AG Loi S Corrias G Piras P La Colla 1996 2-Sulfonyl-4-chloroanilino moiety: a potent pharmacophore for the anti-human immunodeficiency virus type 1 activity of pyrrolyl aryl sulfones J Med Chem 39 522 530 10.1021/jm950568w 10.1021/jm950568w 1:CAS:528:DyaK28XmvVyj 8558522 (Pubitemid 26041464)
2. J Balzarini 2004 Current status of the non-nucleoside reverse transcriptase inhibitors of human immunodeficiency virus type 1 Curr Top Med Chem 4 921 944 10.2174/1568026043388420 10.2174/1568026043388420 1:CAS:528:DC%2BD2cXjslGhtLo%3D 15134549 (Pubitemid 38864691)
3. G Barbaro A Scozzafava A Mastrolorenzo CT Supuran 2005 Highly active antiretroviral therapy: current state of the art, new agents and their pharmacological interactions useful for improving therapeutic outcome Curr Pharm Des 11 1805 1843 10.2174/1381612053764869 10.2174/1381612053764869 1:CAS:528:DC%2BD2MXkt1Chur8%3D 15892677 (Pubitemid 40668138)
4. FW Bell AS Cantrell M Högberg SR Jaskunas NG Johansson CL Jordan MD Kinnick P Lind JM Morin Jr R Noréen B Öberg JA Palkowitz CA Parrish P Pranc C Sahlberg RJ Ternansky RT Vasileff L Vrang SJ West H Zhang X Zhou 1995 Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs J Med Chem 38 4929 4936 10.1021/jm00025a010 10.1021/jm00025a010 1:CAS:528:DyaK2MXptlyksb4%3D 8523406
5. G Campiani A Ramunno G Maga V Nacci C Fattorusso B Catalanotti E Morelli E Novellino 2002 Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives Curr Pharm Des 8 615 657 10.2174/1381612024607207 10.2174/1381612024607207 1:CAS:528:DC%2BD38XivFynt7Y%3D 11945162
6. E De Clercq 1998 The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection Antiviral Res 38 153 179 10.1016/S0166-3542(98)00025-4 10.1016/S0166-3542(98)00025-4 9754886 (Pubitemid 29065480)
7. E De Clercq 2001 New developments in anti-HIV chemotherapy Farmaco 56 3 12 10.1016/S0014-827X(01)01007-2 10.1016/S0014-827X(01)01007-2 11347962 (Pubitemid 32372575)
8. E De Clercq 2004 Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future Chem Biodivers 1 44 64 10.1002/cbdv. 200490012 10.1002/cbdv.200490012 17191775
9. E De Clercq 2005 Emerging anti-HIV drugs Expert Opin Emerg Drugs 10 241 273 10.1517/14728214.10.2.241 10.1517/14728214.10.2.241 15934866 (Pubitemid 40695127)
10. E De Clercq 2005 New approaches toward anti-HIV chemotherapy J Med Chem 48 1297 1313 10.1021/jm040158k 10.1021/jm040158k 15743172 (Pubitemid 40364540)
11. H Jonckheere J Anne E De Clercq 2000 The HIV-1 reverse transcription (RT) process as target for RT inhibitors Med Res Rev 20 129 154 10.1002/(SICI)1098- 1128(200003)20:2<129::AID-MED2>3.0.CO;2-A 10.1002/(SICI)1098- 1128(200003)20:2<129::AID-MED2>3.0.CO;2-A 1:CAS:528:DC%2BD3cXitVeisLk%3D 10723025
12. AJ Leigh Brown SD Frost WC Mathews K Dawson NS Hellmann ES Daar DD Richman SJ Little 2003 Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population J Infect Dis 187 683 686 10.1086/367989 10.1086/367989 12599087 (Pubitemid 36250034)
13. G Maass U Immendoerfer B Koenig U Leser B Mueller R Goody E Pfaff 1993 Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase Antimicrob Agents Chemother 37 2612 2617 1:CAS:528:DyaK2cXivV2nurw%3D 7509144
14. KG Mizuch NM Kasatkin TM Gel'fer 1957 Reaction of acyl chlorides with some hydroxymethyl compounds Zh Obshch Khim 27 189 195 1:CAS:528: DyaG2sXntFCgtw%3D%3D
15. R Pauwels 2004 New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections Curr Opin Pharmacol 4 437 446 10.1016/j.coph.2004.07.005 10.1016/j.coph.2004.07.005 1:CAS:528:DC%2BD2cXntlGhtL0%3D 15351347 (Pubitemid 40533003)
16. R Pauwels J Balzarini M Baba R Snoeck D Schols P Herdewijn J Desmyter E De Clercq 1988 Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds J Virol Methods 20 309 321 10.1016/0166-0934(88) 90134-6 10.1016/0166-0934(88)90134-6 1:CAS:528:DyaL1cXmt1Wkurs%3D 2460479
17. OS Pedersen EB Pedersen 1999 Non-nucleoside reverse transcriptase inhibitors, the NNRTI boom Antivir Chem Chemother 10 285 314 1:CAS:528:DyaK1MXnvFKrt7w%3D 10628805
18. OS Pedersen EB Pedersen 2000 The flourishing syntheses of non-nucleoside reverse transcriptase inhibitors Synthesis 4 479 495 10.1055/s-2000-6357 10.1055/s-2000-6357
19. A Ranise A Spallarossa S Cesarini F Bondavalli S Schenone O Bruno G Menozzi P Fossa L Mosti M La Colla G Sanna M Murreddu G Collu B Busonera ME Marongiu A Pani P La Colla R Loddo 2005 Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives J Med Chem 48 3858 3873 10.1021/jm049252r 10.1021/jm049252r 1:CAS:528:DC%2BD2MXjvVehsL0%3D 15916438 (Pubitemid 40776861)
20. A Ranise A Spallarossa S Schenone O Bruno F Bondavalli L Vargiu T Marceddu M Mura P La Colla A Pani 2003 Design, synthesis, SAR, and molecular modeling studies of acylthiocarbamates: a novel series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors structurally related to phenethylthiazolylthiourea derivatives J Med Chem 46 768 781 10.1021/jm0209984 10.1021/jm0209984 1:CAS:528:DC%2BD3sXovF2hsw%3D%3D 12593657 (Pubitemid 36258868)
21. J Ren J Diprose J Warren RM Esnouf LE Bird S Ikemizu M Slater J Milton J Balzarini DI Stuart DK Stammers 2000 Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases J Biol Chem 275 5633 5639 10.1074/jbc.275.8.5633 10.1074/jbc.275.8.5633 1:CAS:528: DC%2BD3cXhsFKkt70%3D 10681546 (Pubitemid 30115202)
22. DD Richman SC Morton T Wrin N Hellmann S Berry MF Shapiro SA Bozzette 2004 The prevalence of antiretroviral drug resistance in the United States AIDS 18 1393 1401 10.1097/01.aids.0000131310.52526.c7 10.1097/01.aids.0000131310. 52526.c7 15199315 (Pubitemid 38925131)
23. Silverman RB (2004) The organic chemistry of drug design and drug action. Elsevier, Amsterdam, pp 17-20
24. M Sova A Perdih M Kotnik K Kristan TL Rižner T Solmajer S Gobec 2006 Flavonoid and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study J Biol Chem 275 5633 5639
25. A Spallarossa S Cesarini A Ranise O Bruno S Schenone P La Colla G Collu G Sanna B Secci R Loddo 2008 Novel modifications in the series of O-(2-phthalimidoethyl)-N-substituted thiocarbamates and their ring-opened congeners as non-nucleoside HIV-1 reverse transcriptase inhibitors Eur J Med Chem 10.1016/j.ejmech.2008.09.024
26. A Spallarossa S Cesarini A Ranise S Schenone O Bruno A Borassi P La Colla M Pezzullo G Sanna G Collu B Secci R Loddo 2008 Parallel synthesis, molecular modelling and further structure-activity relationship studies of new acylthiocarbamates as potent non-nucleoside HIV-1 reverse transcriptase inhibitors Eur J Med Chem 10.1016/j.ejmech.2008.10.032
27. C Tantillo J Ding A Jacobo-Molina RG Nanni PL Boyer SH Hughes R Pauwels K Andries PA Janssen E Arnold 1994 Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance J Mol Biol 243 369 387 10.1006/jmbi.1994.1665 10.1006/jmbi.1994.1665 1:CAS:528:DyaK2cXmvFWrt7k%3D 7525966
28. Thomas G (2000) Medicinal chemistry. Wiley, New York, pp 40-42
29. R Vig C Mao TK Venkatachalam L Tuel-Ahlgren EA Sudbeck FM Uckun 1998 Rational synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase Bioorg Med Chem 6 1789 1797 10.1016/S0968-0896(98)00108-4 10.1016/S0968-0896(98)00108-4 1:CAS:528:DyaK1cXntlOhtLk%3D 9839009 (Pubitemid 28524233)